glp 1 agonist liver disease Effects of GLP-1 receptor agonists on the degree of fibrosis and CRP in non-alcoholic fatty liver and non-alcoholic steatohepatitis: A systematic review and meta-analysis Revolutionizing MASLD treatment with GLP-1

The purpose of this review is to further elucidate the mechanism of action of GLP-1RAs in helping individuals with overweight or obesity to achieve and maintain weight loss

Private insurers in So Paulo and Rio logged a 45% annual jump in once-weekly GLP-1 scripts in 2025, showing that convenience translates to volume gains once costs moderate

4,9 References Celletti, F., Farrar, J., & De Regil, L

Surging demand has incentivized GLP-1 manufacturers and developers to increase their capital spending and accelerate facility projects, but short-term capacity expansion alone wont be enough

Sensitivity analyses We conducted two sensitivity analyses to ensure the robustness of our findings due to the heterogeneous nature of adverse CVEs

The study was conducted in accordance with the ethical standards outlined in the Declaration of Helsinki and was approved by the institutional review board